Research project

Steele - Janssen - Overcoming resistance mechanisms to ibrutinab conferred by the lymph node microenvironment

  • Other researchers:
  • Research funder:
    Janssen Research & Development LLC
  • Status:
    Not active

Staff

Other researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Research outputs